|
The document details a study on the acute toxicity of perfluorooctanesulfonate (PFOS) to the earthworm species Eisenia fetida, conducted using OECD Guideline No. 207, with a test substance purity of 86.9% and results analyzed for significant differences from control means.
|
2002 |
AR226-1106
|
ZBqrmepBj0jwpJyx0QOxXKzDL |
58 |
|
This document is a bibliography listing literature related to PFOS and N-EtFOSE alcohol, indexed for a July 2002 submission, including various studies and articles on the toxicity and environmental impact of these compounds.
|
2002 |
AR226-1110
|
rBE2j73Y3Q3Ln5V1LmRo2qZRe |
3 |
|
The memorandum details a meeting on August 13, 2002, between EPA officials and corporate executives from the Fluoropolymer Manufacturers Group to discuss toxicological data and human exposure levels related to perfluorooctanoic acid (PFOA), highlighting concerns about its hazards and the need for continued collaboration and clear public communication regarding these issues.
|
2002 |
AR226-1112
|
KJYV1rnxbQdGergr8n5bLKkYw |
3 |
|
This is a memorandum from the EPA's Office of Prevention, Pesticides and Toxic Substances regarding a presentation by the Fluoropolymer Group, related to the administrative record AR-226 on PFOS, PFOA, and telomers.
|
2002 |
AR226-1114
|
zb0nrByx19aDdv4mM0zYXG32R |
3 |
|
This is a letter from the Environmental, Safety and Occupational Health department discussing the risks associated with AFFF fire-fighting foam and recommending medical monitoring for firefighters exposed to PFOS.
|
2002 |
AR226-1113
|
kk5EpVdjXEaz485q0yXxwdQB |
11 |
|
This document is a request from the OECD Environment, Health and Safety Division for member countries to provide information on current or planned risk management activities regarding PFOS (Perfluorooctane Sulfonate) following a draft assessment that identified PFOS as persistent, bioaccumulative, and toxic.
|
2002 |
AR226-1115
|
gbQOM06Xkd3nNMQ9B5Ox2Q5Vq |
2 |
|
The memorandum summarizes a meeting held on August 30, 2002, between EPA toxicologists and the Fluoropolymer Manufacturers Group to discuss findings from two toxicology studies on ammonium perfluorooctanoate (APFO), where EPA recommended reanalysis of estrus cyclicity data and an analysis of implantation losses, which the industry accepted.
|
2002 |
AR226-1117
|
1J7mEYK42dDXRzBjK03Xy635 |
3 |
|
The document discusses a draft exposure data gaps discussion on PFOA, developed by the EPA at the request of the Fluoropolymer Manufacturing Group and the Telomer Research Program, highlighting concerns about PFOA risks based on human blood monitoring data and suggesting the need for a detailed lifecycle assessment of commercial activities related to PFOA.
|
2002 |
AR226-1120
|
pmLxx8YejmJEY3kQKgL9YXGMX |
4 |
|
The document is a correspondence from The Society of the Plastics Industry, Inc. (SPI) to the EPA, providing the attendee list and presentation slides from a web conference on fluoropolymer manufacturers' programs related to EPA concerns about perfluorinated compounds.
|
2002 |
AR226-1121
|
NezMoe14EbgnOZ2NnG6LVOM88 |
13 |
|
This letter from the EPA responds to questions from the OECD regarding risk management activities related to perfluorooctane sulfonate (PFOS), detailing the identification of exposure situations in the U.S. and referencing available data on PFOS exposure levels in humans and wildlife.
|
2002 |
AR226-1116
|
44YZe5rpkZvpowLeg1zKq0rEx |
42 |
|
The memorandum summarizes a September 12, 2002 conference call between the EPA and industry participants regarding data gaps on exposure issues related to perfluorooctanoic acid (PFOA) and telomer chemicals, where the industry reported on the availability and generation of relevant data.
|
2002 |
AR226-1122
|
10ZXD3q4gMG2ZwBYxqrNx1zBd |
2 |
|
This document is a correspondence from 3M to the EPA regarding the submission of raw estrous cycling data and analyses related to toxicology studies on ammonium perfluorooctanoate (APFO) as part of ongoing discussions about perfluorinated compounds.
|
2002 |
AR226-1123
|
zoxJzRx61px6rORqRDeq11zgn |
2 |
|
This document presents estrous cycling and litter observation data from a study evaluating the reproductive effects of APFO (ammonium perfluorooctanoate) on rats, detailing cycle lengths, incidence of aberrant cycles, and litter outcomes across various dose groups.
|
2002 |
AR226-1125
|
kgVn20BJ6eYg7Oyxn3dBnjMB |
4 |
|
The memorandum discusses the revision of the PFOA hazard assessment by the EPA's Office of Pollution Prevention and Toxics, highlighting new toxicological data indicating potential reproductive/developmental toxicity and unexplained low-level exposures in the general population.
|
2002 |
AR226-1127
|
7ObVX5NRBL1Nv5p3eE8G2rXMa |
2 |
|
The memorandum discusses a study comparing vaginal cycling in F1 female rats treated with 30 mg/kg of PFOA (APFO) versus control, concluding that there were no significant differences in cyclicity between the two groups.
|
2002 |
AR226-1128
|
KJXkOp4R4ZQVvZNkdN8QJEyyo |
2 |
|
The document is a communication from the EPA regarding the Revised Draft Hazard Assessment of Perfluorooctanoic Acid (PFOA) and its salts, which updates previous assessments by incorporating new studies, including a two-generation reproductive study in rats and a six-month monkey study.
|
2002 |
AR226-1130
|
k6bnyygzrajrm1oZqRDEJDxNb |
1 |
|
The document details the estrous cycle evaluation for female rats in a study on Ammonium Perfluorooctanoate (APFO), sponsored by 3M, as part of a two-generation reproduction study protocol.
|
2002 |
AR226-1124
|
O1LRN1QM2614jngv6q6gRazv1 |
43 |
|
The memorandum discusses focused statistical analyses of data related to ammonium perfluorooctanoate (APFO) and its effects on preweaning loss, following a meeting between industry representatives and EPA staff regarding findings from a study by York (2002) that reported no significant differences in various reproductive outcomes among treatment groups.
|
2002 |
AR226-1133
|
Jv87g6KmXK5oEBko5pwE0mBr |
38 |
|
The document is a revised draft hazard assessment by the U.S. Environmental Protection Agency evaluating the potential human health and environmental hazards associated with perfluorooctanoic acid (PFOA) and its salts, primarily focusing on toxicological data available as of September 2002.
|
2002 |
AR226-1131
|
6BGvoZOK5BVJnokwqL5XmX2am |
105 |
|
3M Specialty Materials submitted additional comments to the EPA regarding the Draft Hazard Assessment of PFOA and its salts, emphasizing the need to include new human health data and address specific issues related to the Cottage Grove mortality study.
|
2002 |
AR226-1134
|
R2ddBaada41m8Y67L66M61K9v |
15 |
|
The document is a communication from the EPA regarding the November 4, 2002 edition of the Revised Draft Hazard Assessment of Perfluorooctanoic Acid (PFOA) and its salts, which updates previous drafts and incorporates new studies and comments, and is part of the publicly accessible Administrative Record AR226.
|
2002 |
AR226-1135
|
wqqNzoxVNVZ6xk42OMYpjXKZd |
1 |
|
3M submitted a TSCA section 8(e) substantial risk notice to the EPA regarding findings from a toxicity study on perfluorohexane sulfonate potassium salt (PFHS), indicating adverse effects in parental male rats, including increased liver weight and thyroid changes, while no effects were observed in parental females.
|
2002 |
AR226-1138
|
3e4GoZ89VmYzKLMxab9aB4RmO |
2 |
|
The document summarizes a meeting on October 17, 2002, between EPA officials and DuPont representatives to discuss perfluorooctanoic acid (PFOA) and ammonium perfluorooctanoate (APFO), focusing on DuPont's efforts to assess PFOA exposure and pharmacokinetics related to its use in fluoropolymer manufacturing.
|
2002 |
AR226-1139
|
e1xmRrLZDnb2Q77OB6LR4g5z4 |
1 |
|
The document is a revised draft hazard assessment detailing a study that identified levels of PFOA and six other fluorochemicals in the serum of 645 American Red Cross blood donors across six U.S. regions, using high-pressure liquid chromatography for analysis.
|
2002 |
AR226-1132
|
G6wxY5qOMkXZkMjVebeJJkxYq |
302 |
|
The document is a revised draft hazard assessment by the U.S. Environmental Protection Agency evaluating the potential human health and environmental hazards associated with perfluorooctanoic acid (PFOA) and its salts, primarily focusing on toxicology data for ammonium perfluorooctanoic acid (APFO) as of October 2002.
|
2002 |
AR226-1136
|
peKXRBLYqZeXK0g2Np63M11OE |
107 |
|
The document provides an update on the Telomer Research Program (TRP) presented to the U.S. EPA, detailing the production mass balance of telomer compounds, including PFOA, and outlining ongoing studies related to toxicology, environmental fate, and potential consumer exposure routes.
|
2002 |
AR226-1141
|
QXrqyv7499MZ1arnDDZZKdwVv |
48 |
|
This is a letterhead cover page from an unspecified organization, with no analytical content retained in the OCR.
|
2002 |
AR226-1143
|
YrbDeR5eN7xKexj76YzDjz8gE |
1 |
|
This is a letter from the EPA's Office of Prevention, Pesticides and Toxic Substances dated December 9, 2002, addressed to interested parties regarding unspecified matters.
|
2002 |
AR226-1144
|
9J52d7pn6oj21wYjw28qKnMzL |
1 |
|
This is a correspondence from DuPont, dated December 4, 2002, transmitting both sanitized and confidential presentations made to the U.S. EPA during a meeting on November 25, 2002.
|
2002 |
AR226-1146
|
DMn9je5mXpgNm4QK10n1erKkQ |
1 |
|
This document is a communication from 3M to the EPA detailing their voluntary submission of data on perfluorooctane sulfonates and related compounds, including various analytical studies on fluorochemicals in human serum and plasma, with a focus on the validation of analytical methods for PFOS and PFOA.
|
2002 |
AR226-1148
|
Y9DogZZDGya9a7MNvvLKXB4jy |
2 |
|
The EPA issued a final rule establishing a significant new use rule (SNUR) for perfluoroalkyl sulfonates, including PFOSH and its salts, requiring manufacturers and importers to notify the agency 90 days prior to commencing manufacture or import due to potential hazards to human health and the environment.
|
2002 |
AR226-1145
|
YDvBQ7RRxDry1GDyvnV2kDLan |
14 |
|
This is a biodegradation study report (Revision 1) prepared by Pace Analytical Services for 3M, focusing on the biodegradation screening of telomer-type alcohols, with project initiation on August 9, 2000, and completion on September 18, 2001.
|
2002 |
AR226-1149
|
ppM2EwZ2wVgnmeX9g5kJrb0rE |
38 |
|
The document is a presentation by DuPont to the U.S. Environmental Protection Agency on November 25, 2002, detailing their product stewardship efforts and updates on the toxicology, environmental fate, and risk characterization of fluorotelomer products, including PFOA and related substances.
|
2002 |
AR226-1147
|
DMBKpV0jrYbXovebNOZaEgYvB |
65 |
|
The document discusses the collaborative efforts of OECD member countries, led by the US and UK, to assess the environmental and human health hazards of perfluorooctane sulfonate (PFOS) following 3M's decision to phase out its manufacture and use starting in 2001.
|
2002 |
AR226-1140
|
K5E8wQzJyNpXy27nLGVq9qa0 |
362 |
|
3M submitted a TSCA 8(e) notice to the EPA detailing a study that found increased levels of perfluorooctanesulfonate (PFOS) and perfluorohexanesulfonate (PFHS) in the liver and serum of rats after repeated dermal exposure to certain carpet protector products, although no toxicity was observed.
|
2002 |
AR226-1153
|
N2M87g5GoG1rzq98JXxz6LBkD |
2 |
|
This document appears to be a lab report detailing the analysis of various chemical components, including fluorochemicals and solvents, but the specific context and analytical results are not clearly presented due to OCR issues.
|
2002 |
AR226-1154
|
OEoZgk78ndkYakog6M2VwxOvw |
3 |
|
The Environmental Working Group's policy memo critiques the West Virginia Department of Environmental Protection's assessment of perfluorooctanoic acid (PFOA) contamination in drinking water, highlighting significant inaccuracies in the representation of PFOA's toxicity and the establishment of drinking water safety levels.
|
2002 |
AR226-1156
|
M86QvbdGMVjGQyqbYnwJz5nL |
12 |
|
The Little Hocking Water Association reported C-8 (PFOA) test results from multiple wells, with levels ranging from 0.42 to 37.1 ppb, and noted the absence of results for Test Well #4 from the February 22, 2002 sampling.
|
2002 |
AR226-1157
|
ExGNp6NNzvoMJ6dERq00Y43aV |
7 |
|
The Environmental Working Group received a letter from the Little Hocking Water Association expressing concern about C-8 (PFOA) contamination in their drinking water supply, with levels detected as high as 78.0 ppb, significantly exceeding those found in West Virginia water supplies.
|
2002 |
AR226-1158
|
n3zwyw3myOVaKrjxe2Dq7VGG |
1 |
|
This document is a letter from Robert A. Bilott to Mary Dominiak at the EPA, submitting documents related to ammonium perfluorooctanoate (PFOA, also known as C-8) for inclusion in Administrative Record 226.
|
2002 |
AR226-1159
|
3egjjjQaynBbdDO0NYgwEn7aD |
1 |
|
This is a letter from Taft, Stettinius & Hollister LLP dated April 12, 2002, addressing multiple recipients regarding the availability of over 160,000 pages of documents from DuPont related to ammonium perfluorooctanoate (C-8) and the offer to share this data with environmental agencies under a consent order.
|
2002 |
AR226-1160
|
dO88ELKNvxqY8JOwZydyMrRG |
3 |
|
The document is a study report from 3M titled "Analysis of Endogenous Fluorochemicals in Normal Pooled Human Serum and Plasma," conducted under TSCA GLP standards, which examines the presence of fluorochemicals, including PFOA and PFOS, in human serum and plasma.
|
2002 |
AR226-1151
|
Rzaee1p9KmYVGbw1J3GX0G9B |
225 |
|
This document discusses the levels of perfluorooctane sulfonate (PFOS) and related compounds found in the blood of Japanese individuals, highlighting the widespread contamination of these substances in biological media and their prevalence in wildlife globally.
|
2002 |
AR226-1279
|
7VOyx5Nv1Z3M8NdYq75eGbnB |
4 |
|
This document is a correspondence from Roberta Bilott regarding the IRIS submission for Perfluorooctanoic Acid - Ammonium Salt (C-8) related to ongoing litigation against E.I. duPont de Nemours and Company concerning contamination of drinking water supplies.
|
2002 |
AR226-1161
|
zDnxpYj39jXDXjyqokZR2qLa |
35 |
|
This document from DuPont discusses the results of C-8 (PFOA) concentration sampling in public water supplies along the Ohio River, indicating low levels detected and a subsequent reduction in sampling frequency, with quarterly monitoring continuing at three specific locations.
|
2002 |
AR226-1165
|
Nw7wGaro0xB2p8JdZjymbBvb |
6 |
|
This is a draft report detailing Ohio River water sampling results related to C-8 analyses conducted by DuPont for the Washington Works facility and the Letart landfill, as part of a multi-media Consent Order with West Virginia environmental agencies.
|
2002 |
AR226-1166
|
1Q2VLVbXN3m9N77LEyL4mrGpj |
33 |
|
The document is a September 2002 surface water monitoring report for the Washington Works facility and local landfills in West Virginia, focusing on C-8 (PFOA) analytical results.
|
2002 |
AR226-1167
|
NG2LM0Jgd6vradXOrX7w1JV2R |
42 |
|
The document is a Third Quarter 2002 Surface Water and Groundwater Monitoring Report for the Washington Works Facility and local landfills in Washington, WV, focusing on C-8 (PFOA) analytical results in both surface water and groundwater.
|
2002 |
AR226-1168
|
0gRDG5NqYmLy8xzjnjZLJB6Gm |
79 |
|
The document is a DuPont report detailing the determination of the ultraviolet spectrum for 8-2 Telomer B Alcohol (C8F17CH2CH2OH), conducted under the Telomer Research Program, with a completion date of July 16, 2002.
|
2002 |
AR226-1289
|
JJoj8kygGjXrE0OBygNnpKv1B |
8 |
|
The document is a letter from Robert A. Bilott to Mary Dominiak at the EPA, submitting various documents related to PFOA for inclusion in Administrative Record 226, including letters and consent orders involving DuPont and public health concerns in West Virginia.
|
2002 |
AR226-1169
|
4JnbNovJ2G3edBdr0nG547koR |
3 |
|
The document summarizes a two-generation reproduction study of Ammonium Perfluorooctanoate (APFO) in rats conducted by 3M, indicating that while parental animals showed more severe effects than offspring, there were suggestive reproductive effects such as decreased pup weights and altered estrous cyclicity at a dose of 30 mg/kg/day, leading DuPont to conclude that APFO is not
|
2002 |
AR226-1307
|
jyE0EXBdq7eVXX3mDw4j0OKL2 |
10 |
|
The document is a report on a subchronic toxicity study of 8-2 Telomer B Alcohol conducted by Clariant and E.I. du Pont de Nemours and Company, which evaluated the effects of the substance on male and female rats over a 90-day period.
|
2002 |
AR226-1341
|
OJyao9kr005beJor1j1b5M4pM |
8 |
|
The document reports on the physical-chemical properties of 8-2 Telomer B alcohol, including its ultraviolet spectrum, vapor pressure, and water solubility, with findings indicating low solubility and specific vapor pressure measurements.
|
2002 |
AR226-1347
|
peKGOk7ME2J6k9azQ9y2qdmnk |
1 |
|
The document reports on a study conducted by DuPont Central Research & Development that assessed the aqueous stability of 8-2 Telomer B Alcohol (8-2 TBA) under various pH conditions, finding it stable at pH 4, 7, and 9 at 50°C and at pH 1.2 at 37°C.
|
2002 |
AR226-1348
|
OErZRod3X816bOwZGkOn7a9Jp |
2 |
|
This is an EPA Order on Consent regarding E. I. du Pont de Nemours and Company's Washington Works Facility, addressing the release of ammonium perfluorooctanoate (C-8) into the environment and its detection in local drinking water sources.
|
2002 |
AR226-1172
|
JNR7N3oO0danJB9JEDV8LgbEv |
10 |
|
The document is a correspondence from Taft, Stettinius & Hollister LLP regarding a Consent Order between the West Virginia Department of Environmental Protection and DuPont related to contamination of drinking water with ammonium perfluorooctanoate (C-8) from DuPont's Washington Works facility.
|
2002 |
AR226-1174
|
vgZj15DVJexeKrgyvwR78qBY |
3 |
|
This letter from the West Virginia Department of Environmental Protection addresses inquiries from Robert A. Bilott regarding the state's decision not to establish a second laboratory for C8 (PFOA) water testing, affirming reliance on the certified Exygen lab, and discusses representation at an upcoming toxicologists meeting.
|
2002 |
AR226-1177
|
q322n1Dzr3QrgnmJg19oLvzMG |
2 |
|
The document is a response from the EPA to Robert A. Bilott regarding a consent order with E.I. du Pont de Nemours & Company (DuPont) to address concerns about ammonium perfluorooctanoate (PFOA) contamination in drinking water in Parkersburg, West Virginia, acknowledging that PFOA is not currently regulated under the Safe Drinking Water Act but emphasizing
|
2002 |
AR226-1179
|
jjbxO80Oab40Xe8Y0pvZyg4y |
2 |
|
This is a cover letter from Taft Stettinius & Hollister LLP, dated May 7, 2002, transmitting Section 6 of DuPont's June 1999 RCRA Facility Investigation Report regarding C-8 screening levels in drinking water to various recipients, including members of the CAT Team and EPA officials.
|
2002 |
AR226-1180
|
YGomRN0XjjR2a5Z9yYmmeYeD |
22 |
|
This letter from the West Virginia Department of Environmental Protection responds to inquiries from Robert A. Bilott regarding the absence of documents related to the CAT team's position on health protective levels for C-8 (PFOA) prior to their upcoming meeting.
|
2002 |
AR226-1181
|
Em2Xy02Bmq3jQB26ja1bkGkK4 |
2 |
|
This is a letter from Taft, Stettinius & Hollister LLP dated June 10, 2002, regarding the C-8 toxicity assessment under a consent order involving DuPont and the State of West Virginia, addressed to various environmental and legal representatives.
|
2002 |
AR226-1182
|
XOGxwEXdkXge7wYBqmZkREgvy |
15 |
|
The document is a court injunction order concerning a motion by plaintiffs Jack W. Leach et al. against E.I. Du Pont De Nemours and Company and the West Virginia Department of Environmental Protection, regarding the failure to produce records related to the C-8 investigation, specifically concerning the destruction of documents by Dee Ann Staats, Ph.D.
|
2002 |
AR226-1183
|
9Jnx52xwGV9Mvo0D1jbygGZMV |
6 |
|
The document is a response from the EPA to Robert A. Bilott regarding his request for informal discussions about the C-8 Assessment of Toxicity Team meeting related to PFOA, indicating that the EPA cannot participate due to limited resources.
|
2002 |
AR226-1186
|
jBDK3rQGeLDy7190vJ0Z8KY65 |
1 |
|
This document discusses the transition of attorney Joe Dawley from representing E.I. duPont de Nemours and Company in C-8 (PFOA) litigation to becoming the General Counsel for the West Virginia Department of Environmental Protection, highlighting concerns about his prior involvement in compliance issues related to the lawsuit.
|
2002 |
AR226-1187
|
Yr3m7KDN3pe3NJXJrwjRN4x9E |
13 |
|
This letter from Taft, Stettinius & Hollister LLP addresses the West Virginia Department of Environmental Protection's deviation from the Consent Order regarding the assessment of C-8 (PFOA) toxicity issues by the C-8 Assessment of Toxicity Team.
|
2002 |
AR226-1188
|
7Mv6pBBYRrxmeMORe2gJ19BwB |
17 |
|
The document provides finalized C-8 (PFOA) results for public water supplies sampled along the Ohio River in West Virginia and Ohio, detailing findings from multiple sampling events conducted by DuPont Washington Works.
|
2002 |
AR226-1190
|
xz46bpRV58m16VDkq9z3Q7GK6 |
7 |
|
This final report details a 4-week capsule toxicity study of Perfluorooctane Sulfonic Acid Potassium Salt (PFOS) conducted on Cynomolgus monkeys by Covance Laboratories for 3M, noting compliance with EPA Good Laboratory Practice standards despite a GLP deviation during prestudy procedures.
|
2002 |
AR226-1355
|
QJ2jE242LOJEqBQygVXEQ7oG7 |
239 |
|
This document is a One-Mile Radius Survey and C-8 Sampling Report from August 2002, detailing the results of perfluorooctanoic acid (C-8) analyses in groundwater and surface water in Washington County, Ohio, as part of a consent order involving DuPont and West Virginia environmental agencies.
|
2002 |
AR226-1191
|
pepepeby677Me7ZKDvE9ZpR7D |
46 |
|
The document is a July 2002 Surface Water Monitoring Report for the Washington Works Facility and local landfills in West Virginia, detailing C-8 (PFOA) analytical results and concentrations in surface water samples.
|
2002 |
AR226-1193
|
15VgrYL1OmzzG09kba0oE3Y8q |
50 |
|
The document is a Two-Mile Radius Survey and C-8 Sampling Report from the DuPont Washington Works Facility and local landfill in West Virginia, detailing the analysis and results of perfluorinated compound (C-8) sampling conducted between March and May 2002.
|
2002 |
AR226-1192
|
5b3nLD3Baggvvj423RbB01jqN |
78 |
|
The document is a compilation of historical data on ammonium perfluorooctanoate (C-8) from DuPont's Washington Works main plant and landfills, detailing laboratory analyses and environmental quality assessments as of January 2002.
|
2002 |
AR226-1194
|
gDr381m51yab81dmZQ5KRNBvV |
172 |
|
The document is a bacterial reverse mutation test report for perfluorooctane sulfonyl fluoride (POSF), sponsored by 3M and conducted by Huntingdon Life Sciences, issued on October 23, 2002.
|
2002 |
AR226-1200
|
rBoyMy7MBaDrK4v3GRQ1we9Vv |
42 |
|
This document is a report from 3M detailing an in vitro mammalian chromosomal aberration test conducted on perfluorooctanesulfonyl fluoride (POSF) using human lymphocytes, issued on October 22, 2002.
|
2002 |
AR226-1201
|
RwN3ydzBO5JY3M82v6bJ8O78 |
47 |
|
The document is a report from 3M detailing an in vitro mammalian chromosome aberration test conducted on perfluorooctanesulfonyl fluoride (POSF) using human lymphocytes, issued on October 22, 2002.
|
2002 |
AR226-1359
|
omov5yJLZmZnLD2G3L7GYew28 |
28 |
|
The document is a report from 3M detailing a bacterial reverse mutation test for perfluorooctanesulfonyl fluoride (POSF), conducted by Huntingdon Life Sciences, and issued on October 23, 2002.
|
2002 |
AR226-1360
|
QMaDxmm0wZezXaDarbO7gw3y8 |
29 |
|
This document reports on a survey conducted by Entrix, Inc. for 3M, analyzing selected fluorochemicals, including PFOA and PFOS, in water, sediment, and fish samples from the Decatur, Alabama area in 2002.
|
2002 |
AR226-1364
|
pBvNvodBMV6VZZqRv8MD5k8bD |
36 |
|
The document is a study report by Mark E. Ellefson from the 3M Environmental Laboratory detailing the analysis of samples from the Tennessee River Valley, focusing on perfluorinated compounds, with a completion date of December 17, 2002, and a revised report issued on January 6, 2003.
|
2002 |
AR226-1365
|
qa3V008MQZKLyavj99b1avBaK |
285 |
|
The document is a final report on a one-generation reproduction study of PFOS conducted in rats, detailing methods, results, and conclusions regarding the effects of PFOS in relation to mevalonic acid/cholesterol challenge and the no-observed-effect level (NOEL).
|
2002 |
AR226-1357
|
ZnV6Mgxrer66v6brG38Y10zJ0 |
1092 |
|
The document discusses changes in the environmental hazard narrative for PFOA, noting a revision in the Margin of Exposure from 300 to 1000, which results in a new drinking water guideline of 10 ug/L, lower than the previously stated 14 ug/L, prompting a need to correct representations made to EPA Region 3 regarding safe drinking water standards.
|
2002 |
AR226-1690
|
O15kbmEVpnN99B03vkX2bZdrQ |
1 |
|
The document discusses the sharing of a draft monograph related to PFOA by DuPont with regulatory agencies, emphasizing the company's conservative approach in setting its CEG (concentration exposure guideline) and addressing concerns about potential FOIA requests.
|
2002 |
AR226-1691
|
BywMwX1R02MK5O4Yj7daevvBX |
1 |
|
The document describes the ongoing RCRA interim remedial measures program at the 3M Decatur site, focusing on the construction of a containment structure for an inactive landfill to mitigate groundwater contamination, with key components including a subsurface sheet-piling barrier and an upgraded multilayer cap to prevent precipitation infiltration.
|
2002 |
AR226-1700
|
o9aN2dGjkZo32z5JyRkYg0VxD |
1 |
|
The document is a December 2002 surface water monitoring report for the Washington Works Facility and local landfills in Washington, WV, focusing on C-8 (PFOA) analytical results.
|
2002 |
AR226-1234
|
zzJDDmV3JNG27XKpRx5nMy1Q7 |
58 |
|
The document reports on a study conducted by Dr. U. Noack-Laboratorium to determine the acute toxicity of a saturated solution of 1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro- to zebrafish over 96
|
2002 |
AR226-1424
|
3N5VaEM82m9kqqNp9Bz32xnyD |
2 |
|
This document from DuPont Engineering details the results of C-8 (PFOA) concentration sampling in public water supplies along the Ohio River, indicating that due to very low concentrations, the frequency of sampling was reduced, with quarterly sampling continuing at three specific locations in West Virginia and Ohio.
|
2002 |
AR226-1236
|
3Q9Jjvr63M4eRDVGxg0Q4JpYn |
10 |
|
The document is a Two-Mile Radius Survey and C-8 Sampling Report from Washington County, Ohio, detailing the results of C-8 (PFOA) analyses conducted as part of a consent order between DuPont and West Virginia environmental agencies to assess contamination levels.
|
2002 |
AR226-1235
|
j4RknaDE9DKVE4qzbXNzmv0O |
121 |
|
The document is the Fourth Quarter 2002 monitoring report for surface water and groundwater at the Washington Works facility and local landfills, focusing on C-8 (PFOA) analytical results and environmental assessments in Washington, WV.
|
2002 |
AR226-1233
|
MJ53j2nz4ma7qrqVNRZGwggJ9 |
170 |
|
The document is a report titled "Perfluoroalkylated substances - Aquatic environmental assessment" authored by researchers from the University of Amsterdam and RIKZ, which evaluates the production, use, emissions, and environmental behavior of perfluoroalkyl substances (PFAS) in the Netherlands.
|
2002 |
AR226-1237
|
ExQ7518BR0bMvdzp6KxE1LBjL |
100 |
|
This document reviews the genotoxicity, carcinogenicity, developmental, and reproductive effects of perfluorooctanoate (PFOA) based on available animal and human studies, concluding that while laboratory studies indicate potential health hazards, these effects have not been observed in worker populations, suggesting PFOA does not present an unreasonable risk to human health.
|
2002 |
AR226-1727
|
np1N8YEVvempn1o3ZOoN17Gk2 |
23 |
|
This document is a revised report prepared by Entrix, Inc. for 3M, detailing a survey of selected fluorochemicals, including PFOA and PFOS, in the Decatur, Alabama area based on sampling conducted in 2002.
|
2002 |
AR226-1732
|
99J8aGaawR1maR9waM9eb0kwL |
42 |
|
The document discusses air emissions of C8 (PFOA) from the DuPont facility in West Virginia, highlighting that air modeling indicated concentrations above the established screening levels, prompting a response to concerns raised by attorney Robert A. Bilott on behalf of affected Ohio citizens.
|
2002 |
AR226-1501
|
8RnadOeoJvqQqovGDgMJydeVm |
3 |
|
The document contains E. I. du Pont de Nemours and Company's objections and responses to plaintiffs' discovery requests in a civil action regarding PFOA-related claims in West Virginia.
|
2002 |
AR226-1497
|
NeKv6JyKg572bLBvZMaVnLYQD |
70 |
|
The document is a study report from 3M titled "Analysis of Endogenous Fluorochemicals in Normal Pooled Human Serum and Plasma," conducted under Good Laboratory Practice standards, focusing on the analysis of fluorochemicals, including PFOA and PFOS, in human serum and plasma.
|
2002 |
AR226-1781
|
JNzO3erZ8oKjRpY5wX8OQ60M2 |
226 |
|
3M submitted a series of analytical reports and a biodegradation study to the EPA regarding perfluorooctanoic acid (PFOA) and related compounds, including findings on isomer distribution and validated analytical methods for detecting PFOS in biological samples.
|
2002 |
AR226-1781
|
zQRN9dX8XY0gOOy4On7xe5B1g |
4 |
|
This is a biodegradation study report (Revision 1) prepared by Pace Analytical Services for 3M, detailing the biodegradation screen study for telomer-type alcohols under Project Number E01-0684.
|
2002 |
AR226-1781
|
em24gY3z04zmxYXGvKprz1K79 |
38 |
|
3M submitted a supplemental notice to the EPA regarding draft reproduction studies on Perfluorooctanesulfonate (PFOS) conducted on northern bobwhite and mallard ducks, indicating that while some feed levels caused toxicity, the 10ppm group showed no significant reproductive effects compared to controls, although further analytical results are pending.
|
2002 |
AR226-1781
|
V3e4KyDXoL3zjv9QL0bg32wON |
2 |
|
3M submitted a TSCA 8(e) substantial risk notice to the EPA regarding Ammonium Perfluorooctanoate (APFO), CAS# 3825-26-1, detailing statistically significant adverse effects observed in a reproduction study on rats, including decreased lactation index and delays in sexual maturation, while noting that further analysis is needed to understand the causation of these effects
|
2002 |
AR226-1781
|
B5eMkd12X1M81V3KgZz12xLxX |
1 |
|
3M submitted a supplemental notice to the EPA regarding reproduction studies on Perfluorooctanesulfonate (PFOS) conducted on northern bobwhite and mallard ducks, indicating that while some feed levels caused toxicity, the 10 ppm group showed no significant reproductive effects compared to controls, although further analytical results are pending.
|
2002 |
AR226-1781
|
RayDJ1ndox1LdrG7rpDK72Z58 |
2 |
|
3M submitted a TSCA 8(e) substantial risk notice to the EPA regarding Ammonium Perfluorooctanoate (APFO), highlighting statistically significant adverse effects observed in a reproduction study on rats, including decreased lactation index and delayed sexual maturation, while noting that further analyses are needed to clarify causation.
|
2002 |
AR226-1781
|
qdpo5KwjOXn0b3MbKqL9VxbRn |
1 |
|
The document is an Analytical Phase Report for a reproduction study on PFOS conducted by 3M Environmental Laboratory, detailing compliance with GLP standards and noting exceptions in data collection and sample stability.
|
2002 |
AR226-1743
|
4vLg4X907ROZyqM64QvdeJOv1 |
216 |
|
The document is a final report revision from 3M detailing a study (T-6316.9) on fluorochemical levels, specifically PFOS, in naive rats, aimed at identifying sources of contamination contributing to low-level PFOS body burden in control rats from dietary studies.
|
2002 |
AR226-1527
|
XOZXGraM49dvVmrpYQwRpb4pJ |
23 |